iXensor CEO Carson Chen discusses the future of pandemic prevention at Johnson & Johnson Innovation

TAIPEI, TAIWAN; – May 20, 2021 –  iXensor Co., Ltd. (6734.TWO)
Dr. Carson Chen, CEO of iXensor, today participated in Johnson & Johnson Innovation’s webinar “The Future of Pandemic Prevention: Innovation Ecosystem Collaboration” together with renowned experts including Rick Bright (SVP Pandemic Prevention and Response at Rockefeller Foundation, former director of BARDA) and Professors Jodie McVernon and John Tam.

The panelists addressed the question of how society can prepare itself better for future pandemics and what can be done to prevent them from happening. Carson Chen stressed iXensor’s competence in the area of mobile health and emphasized the importance of mutually beneficial industry partnerships:

”Through collaboration networks, startups like iXensor can run clinical studies more efficiently and thereby facilitate the go-to-market process. Partnerships help us to understand the market better and launch crucial products like our PixoTest® POCT COVID-19 Antigen Test faster”.

He went on to remark that resilience is key when dealing with pandemics while other experts stressed the importance of preparedness. 

About iXensor
iXensor, founded in 2012, is the pioneer of mobile health. iXensor turns smartphones into lab-grade mobile medical diagnostics. In 2017, iXensor introduced the PixoTest® Blood Glucose Monitoring System as the world’s first US FDA approved smartphone camera-based blood test.  Based on its scalable PixoTech® platform, iXensor has ventured into both at-home self-testing and professional clinical diagnostics across infectious diseases, women’s health (Eveline), chronic diseases and cardiovascular diseases. Our vision is to make quality healthcare accessible and timely.

Media Contact
Contact Person: Patrick Liao
Company website: www.ixensor.com
Email: pr@ixensor.com
Phone: +886-928670